Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2020 2
2021 4
2022 7
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Clinical correlates of early onset antipsychotic treatment resistance.
Fonseca de Freitas D, Agbedjro D, Kadra-Scalzo G, Francis E, Ridler I, Pritchard M, Shetty H, Segev A, Casetta C, Smart SE, Morris A, Downs J, Christensen SR, Bak N, Kinon BJ, Stahl D, Hayes RD, MacCabe JH. Fonseca de Freitas D, et al. Among authors: agbedjro d. J Psychopharmacol. 2022 Nov;36(11):1226-1233. doi: 10.1177/02698811221132537. Epub 2022 Oct 21. J Psychopharmacol. 2022. PMID: 36268751 Free PMC article.
A predictor model of treatment resistance in schizophrenia using data from electronic health records.
Kadra-Scalzo G, Fonseca de Freitas D, Agbedjro D, Francis E, Ridler I, Pritchard M, Shetty H, Segev A, Casetta C, Smart SE, Morris A, Downs J, Christensen SR, Bak N, Kinon BJ, Stahl D, Hayes RD, MacCabe JH. Kadra-Scalzo G, et al. Among authors: agbedjro d. PLoS One. 2022 Sep 19;17(9):e0274864. doi: 10.1371/journal.pone.0274864. eCollection 2022. PLoS One. 2022. PMID: 36121864 Free PMC article.
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.
Fonseca de Freitas D, Kadra-Scalzo G, Agbedjro D, Francis E, Ridler I, Pritchard M, Shetty H, Segev A, Casetta C, Smart SE, Downs J, Christensen SR, Bak N, Kinon BJ, Stahl D, MacCabe JH, Hayes RD. Fonseca de Freitas D, et al. Among authors: agbedjro d. J Psychopharmacol. 2022 Apr;36(4):498-506. doi: 10.1177/02698811221078746. Epub 2022 Feb 25. J Psychopharmacol. 2022. PMID: 35212240 Free PMC article.
Transcranial direct current stimulation (tDCS) combined with cognitive training in adolescent boys with ADHD: a double-blind, randomised, sham-controlled trial.
Westwood SJ, Criaud M, Lam SL, Lukito S, Wallace-Hanlon S, Kowalczyk OS, Kostara A, Mathew J, Agbedjro D, Wexler BE, Cohen Kadosh R, Asherson P, Rubia K. Westwood SJ, et al. Among authors: agbedjro d. Psychol Med. 2023 Jan;53(2):497-512. doi: 10.1017/S0033291721001859. Epub 2021 Jul 6. Psychol Med. 2023. PMID: 34225830 Free PMC article. Clinical Trial.
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD.
Lam SL, Criaud M, Lukito S, Westwood SJ, Agbedjro D, Kowalczyk OS, Curran S, Barret N, Abbott C, Liang H, Simonoff E, Barker GJ, Giampietro V, Rubia K. Lam SL, et al. Among authors: agbedjro d. Am J Psychiatry. 2022 Dec 1;179(12):947-958. doi: 10.1176/appi.ajp.21100999. Epub 2022 Nov 9. Am J Psychiatry. 2022. PMID: 36349428 Free PMC article. Clinical Trial.
Can IQ moderate the response to cognitive remediation in people with schizophrenia?
Seccomandi B, Agbedjro D, Bell M, Keefe RSE, Keshavan M, Galderisi S, Fiszdon J, Mucci A, Cavallaro R, Bechi M, Ojeda N, Peña J, Wykes T, Cella M. Seccomandi B, et al. Among authors: agbedjro d. J Psychiatr Res. 2021 Jan;133:38-45. doi: 10.1016/j.jpsychires.2020.12.013. Epub 2020 Dec 4. J Psychiatr Res. 2021. PMID: 33307353
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardiñas AF, Smart SE, Willcocks IR, Holmans PA, Dennison CA, Lynham AJ, Legge SE, Baune BT, Bigdeli TB, Cairns MJ, Corvin A, Fanous AH, Frank J, Kelly B, McQuillin A, Melle I, Mortensen PB, Mowry BJ, Pato CN, Periyasamy S, Rietschel M, Rujescu D, Simonsen C, St Clair D, Tooney P, Wu JQ, Andreassen OA, Kowalec K, Sullivan PF, Murray RM, Owen MJ, MacCabe JH, O'Donovan MC, Walters JTR; Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances (STRATA) Consortium and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC); Ajnakina O, Alameda L, Barnes TRE, Berardi D, Bonora E, Camporesi S, Cleusix M, Conus P, Crespo-Facorro B, D'Andrea G, Demjaha A, Do KQ, Doody GA, Eap CB, Ferchiou A, Di Forti M, Guidi L, Homman L, Jenni R, Joyce EM, Kassoumeri L, Khadimallah I, Lastrina O, Muratori R, Noyan H, O'Neill FA, Pignon B, Restellini R, Richard JR, Schürhoff F, Španiel F, Szöke A, Tarricone I, Tortelli A, Üçok A, Vázquez-Bourgon J. Pardiñas AF, et al. JAMA Psychiatry. 2022 Mar 1;79(3):260-269. doi: 10.1001/jamapsychiatry.2021.3799. JAMA Psychiatry. 2022. PMID: 35019943 Free PMC article.
14 results